Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

- Dermata announced a strategic pivot to develop and commercialize over-the-counter (OTC) skin care treatments -- Dermata plans to launch its first OTC product, a once weekly acne kit with its Spongilla technology, in the middle of 2026 - SAN DIEGO, …
Jetzt den vollständigen Artikel lesen